European Commission Approves Sanofi’s New Sarclisa Administration Method for Multiple Myeloma
The European Commission has approved a subcutaneous version of Sanofi’s Sarclisa, making it the first cancer treatment in the European Union delivered through an on-body injector and expanding options for outpatient and home-based care.